Article
Immunotherapy for colorectal cancer: insight from inherited genetics.
Trends in cancer - 1 May 2024
Tjader Nijole Pollock, Toland Amanda Ewart
Abstract excerpt
Immunotherapy shows efficacy for multiple cancer types and potential for expanded use. However, current immune checkpoint inhibitors (ICIs) are ineffective against microsatellite-stable colorectal cancer (CRC), which is more commonly diagnosed. Immunotherapy strategies for non-responsive CRC, including new targets and new combination therapies, are being tested to address this need. Importantly, a subset of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
